Journal of Clinical and Translational Science (Dec 2017)

Can composite digital monitoring biomarkers come of age? A framework for utilization

  • Christopher Kovalchick,
  • Rhea Sirkar,
  • Oliver B. Regele,
  • Lampros C. Kourtis,
  • Marie Schiller,
  • Howard Wolpert,
  • Rhett G. Alden,
  • Graham B. Jones,
  • Justin M. Wright

DOI
https://doi.org/10.1017/cts.2018.4
Journal volume & issue
Vol. 1
pp. 373 – 380

Abstract

Read online

IntroductionThe application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity, and ease of capture within a decision-making dashboard.MethodsA framework was developed which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite, and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare.ResultsThe de novo framework implies consideration of physiological, behavioral, and environmental factors in the context of biomarker capture and analysis. Application in disease and wellness is highlighted, and incorporation in clinical feedback loops and closed-loop systems is illustrated.ConclusionsThe study of contextualized biomarkers has the potential to offer rich and insightful data for clinical decision making. Moreover, advancement of the field will benefit from innovation at the intersection of medicine, engineering, and science. Technological developments in this dynamic field will thus fuel its logical evolution guided by inputs from patients, physicians, healthcare providers, end-payors, actuarists, medical device manufacturers, and drug companies.

Keywords